Anti-Human VEGF Therapeutic Antibody (HAB1)
The antibody binds to human VEGF with high affinity and inhibits VEGF-induced proliferation of endothelial cells. It can be potentially used in the treatment of cancer, AMD, diabetic retinopathy, and other diseases derived from pathological angiogenesis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-293CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | VEGF (Vascular endothelial growth factor) |
| Species Reactivity | Human |
| Type | Humanized antibody |
| Applications | WB |